Astellas' drug discovery strategy: focus on oncology

Yutaka Yanagita1, Toichi Takenaka

  • 1Astellas Pharma Inc., Tsukuba Research Center, 21 Miyukigaoka, Tsukuba-shi, Ibaraki 305-8585, Japan. yutaka.yanagita@astellas.com

Insights

Astellas pursues precision medicine to develop novel cancer therapies for unmet medical needs. This strategy leverages diverse research platforms and styles across three sites to deliver innovative pharmaceutical products.

Area of Science:

  • Oncology
  • Pharmaceutical Sciences
  • Drug Discovery

Background:

  • Cancer patients often lack effective treatment options.
  • There is a need for innovative and reliable pharmaceutical products.

Purpose of the Study:

  • To outline Astellas's precision medicine strategy in drug discovery.
  • To highlight the goal of delivering novel therapies for cancer patients with no effective treatments.

Main Methods:

  • Focusing drug discovery efforts on a precision medicine strategy.
  • Conducting research at three distinct sites.
  • Utilizing diverse research platforms and styles.

Main Results:

  • Astellas is implementing a precision medicine approach.
  • Research is being conducted across multiple, diverse sites.

Conclusions:

  • Astellas's precision medicine strategy aims to address unmet needs in cancer care.
  • The company's approach integrates diverse research capabilities to drive innovation.

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...